Chemonucleolysis Requires Chymopapain: Should We Accept Its Unavailability?


  • Version
  • 13 Download
  • 448.51 KB File Size
  • March 25, 2008 Create Date

The production of chymopapain and its availability in the United States and Europe has been discontinued by its manufacturer. This creates an untenable and unacceptable situation. Our patients are without chemonucleolysis (CNL), a proven treatment for disc related nerve root pain. FDA confirmed that Chymodiactin®, which is injected during the CNL procedure, was not discontinued for reasons of safety or effectiveness

Phoenix

1635 East Myrtle Avenue, Suite 400
Phoenix, AZ 85020

East Valley

3487 S. Mercy Road
Gilbert, AZ 85297

Scottsdale

8630 E. Via de Ventura, Suite 210
Scottsdale, AZ 85258

LEADERS IN MINIMALLY INVASIVE SPINE CARE
Copyright © 1996-2018 by Anthony T. Yeung, M.D., P.C.
1635 E. Myrtle • Suite 400 • Phoenix, AZ 85020 • 602-944-2900